Optibrium and Lhasa, providers of software for compound design, selection and property prediction, have announced a technology collaboration agreement.
Lhasa’s Derek Nexus platform for knowledge-based prediction of compound toxicity will be integrated as an optional plug-in module for Optibrium’s StarDrop software, that guides the design and selection of high quality compounds in drug discovery.
It is hoped that the combination of these technologies will enable chemists to intuitively balance the reduction of toxicity risk with the other requirements for a successful, safe and efficacious drug in hit-to-lead and lead optimisation.
The software's reporting feature will facilitate collaboration between chemists and expert toxicologists to interpret and understand the relevance of a potential liability, enabling effective, early decision-making regarding the prioritisation of chemistries early in the drug discovery process.
